Semler Scientific Inc
$ 20.33
0.00%
16 Jan - close price
- Market Cap 348,270,000 USD
- Current Price $ 20.33
- High / Low $ 20.33 / 20.33
- Stock P/E 5.04
- Book Value 24.15
- EPS 4.56
- Next Earning Report 2026-03-10
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.01 %
- ROE 0.16 %
- 52 Week High 53.86
- 52 Week Low 14.88
About
Semler Scientific, Inc. is a pioneering healthcare company based in Santa Clara, California, specializing in the development and commercialization of proprietary solutions aimed at enhancing the evaluation and management of chronic conditions. By addressing the critical need for effective chronic disease management tools, Semler is well-positioned to leverage substantial market opportunities and drive innovation in patient care. With a strong commitment to improving clinical outcomes and a strategic vision tailored to meet the demands of an evolving healthcare landscape, Semler presents a compelling investment opportunity for institutional investors seeking growth in the healthcare sector.
Analyst Target Price
$75.33
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-03 | 2025-08-04 | 2025-05-05 | 2025-03-03 | 2024-11-04 | 2024-08-05 | 2024-05-07 | 2024-03-05 | 2023-11-09 | 2023-08-10 | 2023-05-10 | 2023-03-21 |
| Reported EPS | -0.2987 | -0.23 | -6.7426 | 3.4093 | 0.59 | 0.64 | 0.78 | 0.59 | 0.78 | 0.75 | 0.63 | 0.41 |
| Estimated EPS | -0.14 | -0.27 | None | 0.26 | 0.37 | 0.56 | 1.03 | 0.57 | 0.51 | 0.56 | 0.58 | 0.28 |
| Surprise | -0.1587 | 0.04 | 0 | 3.1493 | 0.22 | 0.08 | -0.25 | 0.02 | 0.27 | 0.19 | 0.05 | 0.13 |
| Surprise Percentage | -113.3571% | 14.8148% | None% | 1211.2692% | 59.4595% | 14.2857% | -24.2718% | 3.5088% | 52.9412% | 33.9286% | 8.6207% | 46.4286% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-10 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.25 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SMLR
2026-02-09 01:29:14
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Semler Scientific, Inc. (NASDAQ:SMLR). The firm encourages investors who bought Semler securities before March 10, 2021, and still hold them, to contact them to assist in the investigation into possible corporate wrongdoing by Semler's officers and/or directors. The firm operates on a contingency fee basis, meaning investors incur no upfront cost.
2026-02-05 15:27:55
Johnson Fistel, PLLP has initiated investigations into potential claims against the officers and directors of Replimune Group, Inc. (REPL), Sable Offshore Corp. (SOC), Sarepta Therapeutics, Inc. (SRPT), and Semler Scientific, Inc. (SMLR) for alleged breaches of fiduciary duty. Long-term shareholders holding shares continuously since specific dates prior to alleged wrongdoings may be able to seek corporate governance reforms and the return of company funds. The investigations stem from previously filed securities class action complaints detailing alleged false or misleading statements and omissions by the companies' management.
2026-02-03 11:00:00
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential allegations of corporate wrongdoing against Semler Scientific, Inc. (SMLR). The firm is encouraging Semler investors who purchased securities prior to March 10, 2021, and still hold them, to come forward and assist in the investigation. This action aims to recover investor capital and ensure corporate accountability.
2026-02-01 22:58:44
Strive, a new Bitcoin acquisition entity, has purchased 334 Bitcoins as part of a larger plan to acquire up to 10% of Semler Scientific's (SMLR) shares. This move helps reduce the debt taken on for the Semler deal and positions Strive to influence the medical device company's financial strategy towards Bitcoin.
2026-01-29 08:29:17
Strive, Inc. has successfully completed an oversubscribed follow-on offering, raising $225 million through its Variable Rate Series A Perpetual Preferred Stock, known as SATA. This funding allowed Strive to retire the bulk of its Semler Scientific acquisition debt, specifically $110 million out of $120 million, and to pay off a $20 million loan with Coinbase Credit, leaving its bitcoin holdings unencumbered. Additionally, Strive purchased an extra 333.89 bitcoin for $29 million, bringing its total holdings to 13,131.82 BTC and making it the tenth-largest publicly traded corporate holder of bitcoin globally.
2026-01-29 00:30:40
Strive, a Bitcoin treasury company, announced it has retired 92% of the debt inherited from its acquisition of Semler Scientific and purchased an additional 333.9 Bitcoin. This move follows a successful preferred stock offering that raised $225 million, intended to fund Bitcoin accumulation without increasing leverage. Despite these financial improvements, Strive's shares fell on Wednesday, reflecting ongoing market volatility for corporate Bitcoin strategies.
